{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,25]],"date-time":"2026-04-25T00:29:40Z","timestamp":1777076980403,"version":"3.51.4"},"reference-count":112,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100000923","name":"Australian Research Council","doi-asserted-by":"publisher","award":["IC220100050"],"award-info":[{"award-number":["IC220100050"]}],"id":[{"id":"10.13039\/501100000923","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003327","name":"Cooperative Research Australia","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003327","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100011025","name":"Government of Western Australia","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100011025","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100009727","name":"Hospital Research Foundation","doi-asserted-by":"publisher","award":["2019\/41\\u201383100"],"award-info":[{"award-number":["2019\/41\\u201383100"]}],"id":[{"id":"10.13039\/100009727","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100009727","name":"Hospital Research Foundation","doi-asserted-by":"publisher","award":["2021\/49-QA25312"],"award-info":[{"award-number":["2021\/49-QA25312"]}],"id":[{"id":"10.13039\/100009727","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal for Parasitology: Drugs and Drug Resistance"],"published-print":{"date-parts":[[2025,12]]},"DOI":"10.1016\/j.ijpddr.2025.100606","type":"journal-article","created":{"date-parts":[[2025,8,5]],"date-time":"2025-08-05T21:16:40Z","timestamp":1754428600000},"page":"100606","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"special_numbering":"C","title":["Screening and hit evaluation of a microbial metabolite library against the pathogenic Plasmodium falciparum and Toxoplasma gondii parasites"],"prefix":"10.1016","volume":"29","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-7428-6791","authenticated-orcid":false,"given":"Maria R.","family":"Gancheva","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8709-1897","authenticated-orcid":false,"given":"Emma Y.","family":"Mao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7088-7266","authenticated-orcid":false,"given":"Ornella","family":"Romeo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Daniel","family":"Vuong","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ryan","family":"O'Handley","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5312-2149","authenticated-orcid":false,"given":"Stephen W.","family":"Page","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ernest","family":"Lacey","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5073-1405","authenticated-orcid":false,"given":"Danny W.","family":"Wilson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"107851","key":"10.1016\/j.ijpddr.2025.100606_bib1","article-title":"Antimalarial alkaloid from Hypoestes forskaolii","volume":"211","author":"Abdel-\u064d\u064dSattar","year":"2020","journal-title":"Exp. Parasitol."},{"key":"10.1016\/j.ijpddr.2025.100606_bib2","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1007\/s00709-014-0664-6","article-title":"Identification of inhibitors of Plasmodium falciparum RuvB1 helicase using biochemical assays","volume":"252","author":"Ahmad","year":"2015","journal-title":"Protoplasma"},{"issue":"3","key":"10.1016\/j.ijpddr.2025.100606_bib3","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1016\/S1473-3099(15)00487-9","article-title":"Dihydroartemisinin\u2013piperaquine resistance in Plasmodium falciparum malaria in Cambodia: a multisite prospective cohort study","volume":"16","author":"Amaratunga","year":"2016","journal-title":"Lancet Infect. Dis."},{"issue":"4","key":"10.1016\/j.ijpddr.2025.100606_bib4","doi-asserted-by":"crossref","first-page":"1338","DOI":"10.1128\/AAC.01096-10","article-title":"Thiostrepton and derivatives exhibit antimalarial and gametocytocidal activity by dually targeting parasite proteasome and apicoplast","volume":"55","author":"Aminake","year":"2011","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.ijpddr.2025.100606_bib5","doi-asserted-by":"crossref","first-page":"3315","DOI":"10.1016\/j.bmcl.2006.03.056","article-title":"Design, synthesis, and evaluation of novel kazusamycin A derivatives as potent antitumor agents","volume":"16","author":"Ando","year":"2006","journal-title":"Bioorg. Med. Chem. Lett"},{"issue":"3","key":"10.1016\/j.ijpddr.2025.100606_bib6","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1016\/j.ijantimicag.2017.05.020","article-title":"16-membered macrolide antibiotics: a review","volume":"51","author":"Arsic","year":"2018","journal-title":"Int. J. Antimicrob. Agents"},{"issue":"3","key":"10.1016\/j.ijpddr.2025.100606_bib7","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1038\/s41573-020-00114-z","article-title":"Natural products in drug discovery: advances and opportunities","volume":"20","author":"Atanasov","year":"2021","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.ijpddr.2025.100606_bib8","first-page":"497","article-title":"D\u00e9riv\u00e9s hydrosolubles du facteur IA des pristinamycines: interactions avec le ribosome bact\u00e9rien","volume":"33","author":"Aumercier","year":"1985","journal-title":"Pathol. Biol."},{"issue":"6","key":"10.1016\/j.ijpddr.2025.100606_bib9","doi-asserted-by":"crossref","DOI":"10.1128\/AAC.02699-16","article-title":"Bioluminescence method for in vitro screening of plasmodium transmission-blocking compounds","volume":"61","author":"Azevedo","year":"2017","journal-title":"Antimicrobial Agents & Chemotherapy"},{"key":"10.1016\/j.ijpddr.2025.100606_bib10","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejphar.2021.174661","article-title":"The bacterial thiopeptide thiostrepton. An update of its mode of action, pharmacological properties and applications","volume":"914","author":"Bailly","year":"2022","journal-title":"Eur. J. Pharmacol."},{"issue":"2","key":"10.1016\/j.ijpddr.2025.100606_bib11","doi-asserted-by":"crossref","first-page":"774","DOI":"10.1128\/AAC.00892-07","article-title":"Telithromycin and quinupristin-dalfopristin induce delayed death in Plasmodium falciparum","volume":"52","author":"Barthel","year":"2008","journal-title":"Antimicrobial Agents Chemotherapy"},{"issue":"2","key":"10.1016\/j.ijpddr.2025.100606_bib12","doi-asserted-by":"crossref","first-page":"129","DOI":"10.4103\/2229-5070.190817","article-title":"Toxoplasmosis in HIV infection: an overview","volume":"6","author":"Basavaraju","year":"2016","journal-title":"Tropical Parasitology"},{"issue":"2","key":"10.1016\/j.ijpddr.2025.100606_bib13","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1128\/EC.00229-14","article-title":"Genetic mapping reveals that sinefungin resistance in Toxoplasma gondii is controlled by a putative amino acid transporter locus that can be used as a negative selectable marker","volume":"14","author":"Behnke","year":"2015","journal-title":"Eukaryot. Cell"},{"key":"10.1016\/j.ijpddr.2025.100606_bib14","doi-asserted-by":"crossref","first-page":"3354","DOI":"10.1038\/sj.onc.1204436","article-title":"Staurosporine induces apoptosis through both caspase-dependent and caspase-independent mechanisms","volume":"20","author":"Belmokhtar","year":"2001","journal-title":"Oncogene"},{"issue":"31","key":"10.1016\/j.ijpddr.2025.100606_bib15","doi-asserted-by":"crossref","first-page":"8249","DOI":"10.1039\/D0SC01928C","article-title":"Production of novel pladienolide analogues through native expression of a pathway-specific activator","volume":"11","author":"Booth","year":"2020","journal-title":"Chem. Sci."},{"issue":"22","key":"10.1016\/j.ijpddr.2025.100606_bib16","doi-asserted-by":"crossref","first-page":"4755","DOI":"10.1021\/bi00667a001","article-title":"Cryptopleurine - an inhibitor of translocation","volume":"15","author":"Bucher","year":"1976","journal-title":"Biochemistry"},{"key":"10.1016\/j.ijpddr.2025.100606_bib17","doi-asserted-by":"crossref","DOI":"10.3389\/fcimb.2022.1063407","article-title":"Targeting malaria parasites with novel derivatives of azithromycin","volume":"12","author":"Burns","year":"2022","journal-title":"Front. Cell. Infect. Microbiol."},{"key":"10.1016\/j.ijpddr.2025.100606_bib18","doi-asserted-by":"crossref","first-page":"1261","DOI":"10.3389\/fimmu.2017.01261","article-title":"Potential sabotage of host cell physiology by apicomplexan parasites for their survival benefits","volume":"B","author":"Chakraborty","year":"2017","journal-title":"Front. Immunol."},{"issue":"10","key":"10.1016\/j.ijpddr.2025.100606_bib19","doi-asserted-by":"crossref","first-page":"2411","DOI":"10.1021\/acs.jnatprod.5b00489","article-title":"Actinoramide A identified as a potent antimalarial from titration-based screening of marine natural product extracts","volume":"78","author":"Cheng","year":"2015","journal-title":"J. Nat. Prod."},{"issue":"18","key":"10.1016\/j.ijpddr.2025.100606_bib20","doi-asserted-by":"crossref","first-page":"2938","DOI":"10.1093\/bioinformatics\/btx364","article-title":"UpSetR: an R package for the visualization of intersecting sets and their properties","volume":"33","author":"Conway","year":"2017","journal-title":"Bioinformatics"},{"issue":"1","key":"10.1016\/j.ijpddr.2025.100606_bib21","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1351\/pac200577010007","article-title":"Biodiversity: a continuing source of novel drug leads","volume":"77","author":"Cragg","year":"2005","journal-title":"Pure Appl. Chem."},{"issue":"6","key":"10.1016\/j.ijpddr.2025.100606_bib22","doi-asserted-by":"crossref","first-page":"3670","DOI":"10.1016\/j.bbagen.2013.02.008","article-title":"Natural products: a continuing source of novel drug leads","volume":"1830","author":"Cragg","year":"2013","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.ijpddr.2025.100606_bib23","first-page":"1013","article-title":"DE-175 (spinetoram), a new semi-synthetic spinosyn in development","volume":"3","author":"Crouse","year":"2007","journal-title":"Modern Crop Protection Compounds"},{"issue":"10","key":"10.1016\/j.ijpddr.2025.100606_bib24","doi-asserted-by":"crossref","first-page":"3485","DOI":"10.1128\/AAC.00527-07","article-title":"Multiple antibiotics exert delayed effects against the Plasmodium falciparum apicoplast","volume":"51","author":"Dahl","year":"2007","journal-title":"Antimicrob. Agents Chemother."},{"issue":"70","key":"10.1016\/j.ijpddr.2025.100606_bib25","article-title":"Multiple essential functions of Plasmodium falciparum actin-1 during malaria blood-stage development","volume":"15","author":"Das","year":"2017","journal-title":"BMC Biol."},{"issue":"481","key":"10.1016\/j.ijpddr.2025.100606_bib26","article-title":"An improved SYBR Green-1-based fluorescence method for the routine monitoring of Plasmodium falciparum resistance to anti-malarial drugs","volume":"14","author":"Dery","year":"2015","journal-title":"Malar. J."},{"issue":"6","key":"10.1016\/j.ijpddr.2025.100606_bib27","doi-asserted-by":"crossref","first-page":"933","DOI":"10.1016\/S0092-8674(00)81071-5","article-title":"Toxoplasma invasion of Mammalian cells is powered by the Actin Cytoskeleton of the parasite","volume":"84","author":"Dobrowolski","year":"1996","journal-title":"Cell"},{"issue":"5","key":"10.1016\/j.ijpddr.2025.100606_bib28","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1056\/NEJMoa0808859","article-title":"Artemisinin resistance in Plasmodium falciparum malaria","volume":"361","author":"Dondorp","year":"2009","journal-title":"N. Engl. J. Med."},{"issue":"12","key":"10.1016\/j.ijpddr.2025.100606_bib29","first-page":"510","article-title":"Medicines for malaria venture pandemic box in vitro screening identifies compounds highly active against the tachyzoite stage of Toxoplasma gondii","volume":"8","author":"Dos Santos","year":"2023","journal-title":"Trop. Med. Infect. Dis."},{"issue":"4","key":"10.1016\/j.ijpddr.2025.100606_bib30","doi-asserted-by":"crossref","DOI":"10.1128\/CMR.00057-17","article-title":"Treatment of toxoplasmosis: historical perspective, animal models, and current clinical practice","volume":"31","author":"Dunay","year":"2018","journal-title":"Clin. Microbiol. Rev."},{"issue":"39004","key":"10.1016\/j.ijpddr.2025.100606_bib31","article-title":"A novel pleuromutilin antibacterial compound, its binding mode and selectivity mechanism","volume":"6","author":"Eyal","year":"2016","journal-title":"Sci. Rep."},{"issue":"10","key":"10.1016\/j.ijpddr.2025.100606_bib32","doi-asserted-by":"crossref","first-page":"963","DOI":"10.1016\/j.oret.2022.04.022","article-title":"Prevalence of toxoplasmic retinochoroiditis in an Australian adult population: a community-based study","volume":"6","author":"Ferreira","year":"2022","journal-title":"Ophthalmology Retina"},{"issue":"1","key":"10.1016\/j.ijpddr.2025.100606_bib33","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1002\/cm.970250106","article-title":"Actin in the merozoite of the malaria parasite, Plasmodium falciparum","volume":"25","author":"Field","year":"1993","journal-title":"Cytoskeleton"},{"issue":"12","key":"10.1016\/j.ijpddr.2025.100606_bib34","doi-asserted-by":"crossref","first-page":"2829","DOI":"10.1021\/acs.jnatprod.4c01098","article-title":"In vitro and in vivo leishmanicidal activity of beauvericin","volume":"87","author":"Filho","year":"2024","journal-title":"J. Nat. Prod."},{"issue":"3","key":"10.1016\/j.ijpddr.2025.100606_bib35","first-page":"226","article-title":"On the antibacterial action of cultures of a Penicillium with special reference to their use in the isolation of B. influenza","volume":"10","author":"Fleming","year":"1929","journal-title":"Br. J. Exp. Pathol."},{"issue":"3","key":"10.1016\/j.ijpddr.2025.100606_bib36","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1016\/j.chom.2009.01.011","article-title":"Host cell entry by apicomplexa parasites requires actin polymerization in the host cell","volume":"5","author":"Gonzalez","year":"2009","journal-title":"Cell Host Microbe"},{"issue":"1","key":"10.1016\/j.ijpddr.2025.100606_bib37","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1128\/AAC.47.1.309-316.2003","article-title":"High-throughput growth assay for Toxoplasma gondii using yellow fluorescent protein","volume":"47","author":"Gubbels","year":"2003","journal-title":"Antimicrobial Agents Chemotherapy"},{"issue":"1\u20132","key":"10.1016\/j.ijpddr.2025.100606_bib38","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/j.molbiopara.2013.10.003","article-title":"The effect of fusidic acid on Plasmodium falciparum elongation factor G (EF-G)","volume":"192","author":"Gupta","year":"2013","journal-title":"Mol. Biochem. Parasitol."},{"key":"10.1016\/j.ijpddr.2025.100606_bib39","doi-asserted-by":"crossref","DOI":"10.1128\/aac.01671-23","article-title":"Venturicidin A affects the mitochondrial membrane potential and induces kDNA loss in Trypanosoma brucei","volume":"68","author":"Hauser","year":"2024","journal-title":"Antimicrob. Agents Chemother."},{"issue":"2794","key":"10.1016\/j.ijpddr.2025.100606_bib40","article-title":"Real-time cholesterol sorting in Plasmodium falciparum-erythrocytes as revealed by 3D label-free imaging","volume":"10","author":"Hayakawa","year":"2020","journal-title":"Sci. Rep."},{"issue":"3","key":"10.1016\/j.ijpddr.2025.100606_bib41","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1007\/s10637-013-0046-5","article-title":"A phase I, open-label, single-arm, dose-escalation study of E7107, a precursor messenger ribonucleic acid (pre-mRNA) splicesome inhibitor administered intravenously on days 1 and 8 every 21 days to patients with solid tumors","volume":"32","author":"Hong","year":"2013","journal-title":"Invest. N. Drugs"},{"issue":"1","key":"10.1016\/j.ijpddr.2025.100606_bib42","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/0166-6851(84)90021-5","article-title":"Induction and selection of drug resistant mutants of Plasmodium falciparum","volume":"10","author":"Inselburg","year":"1984","journal-title":"Mol. Biochem. Parasitol."},{"issue":"3","key":"10.1016\/j.ijpddr.2025.100606_bib43","doi-asserted-by":"crossref","first-page":"29","DOI":"10.3390\/antibiotics5030029","article-title":"From Erythromycin to Azithromycin and new potential ribosome-binding antimicrobials","volume":"5","author":"Jeli\u0107","year":"2016","journal-title":"Antibiotics (Basel)"},{"issue":"4","key":"10.1016\/j.ijpddr.2025.100606_bib44","doi-asserted-by":"crossref","DOI":"10.1128\/spectrum.04142-23","article-title":"Identification of fungal natural products with potent inhibition in Toxoplasma gondii","volume":"12","author":"Jiang","year":"2024","journal-title":"Microbiol. Spectr."},{"key":"10.1016\/j.ijpddr.2025.100606_bib45","article-title":"The significant role of the microfilament System in tumors","volume":"11","author":"Jiang","year":"2021","journal-title":"Front. Oncol."},{"issue":"6","key":"10.1016\/j.ijpddr.2025.100606_bib46","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0040355","article-title":"Cryptopleurine targets NF-\u03baB pathway, leading to inhibition of gene products associated with cell survival, proliferation, invasion, and angiogenesis","volume":"7","author":"Jin","year":"2012","journal-title":"PLoS One"},{"issue":"6","key":"10.1016\/j.ijpddr.2025.100606_bib47","article-title":"Characterization of two Malaria parasite Organelle translation elongation factor G proteins: the likely targets of the anti-malarial fusidic acid","volume":"6","author":"Johnson","year":"2013","journal-title":"PLoS One"},{"issue":"7","key":"10.1016\/j.ijpddr.2025.100606_bib48","doi-asserted-by":"crossref","first-page":"2583","DOI":"10.1128\/AAC.01432-05","article-title":"Activity of retapamulin (SB-275833), a novel pleuromutilin, against selected resistant gram-positive cocci","volume":"50","author":"Jones","year":"2006","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.ijpddr.2025.100606_bib49","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1038\/ja.2010.5","article-title":"The spinosyn family of insecticides: realizing the potential of natural products research","volume":"63","author":"Kirst","year":"2010","journal-title":"J. Antibiot."},{"issue":"19","key":"10.1016\/j.ijpddr.2025.100606_bib50","doi-asserted-by":"crossref","first-page":"9047","DOI":"10.1158\/0008-5472.CAN-05-1235","article-title":"Echinomycin, a small-molecule inhibitor of hypoxia-inducible factor-1 DNA-binding activity","volume":"65","author":"Kong","year":"2005","journal-title":"Cancer Res."},{"issue":"9","key":"10.1016\/j.ijpddr.2025.100606_bib51","doi-asserted-by":"crossref","first-page":"570","DOI":"10.1038\/nchembio.2007.16","article-title":"Splicing factor SF3b as a target of the antitumor natural product pladienolide","volume":"3","author":"Kotake","year":"2007","journal-title":"Nat. Chem. Biol."},{"issue":"2","key":"10.1016\/j.ijpddr.2025.100606_bib52","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1128\/AAC.01092-10","article-title":"The antibiotic monensin causes cell cycle disruption of Toxoplasma gondii mediated through the DNA repair enzyme TgMSH-1","volume":"55","author":"Lavine","year":"2011","journal-title":"Antimicrob. Agents Chemother."},{"issue":"5","key":"10.1016\/j.ijpddr.2025.100606_bib53","doi-asserted-by":"crossref","first-page":"780","DOI":"10.2307\/3283622","article-title":"In vitro sensitivity of Plasmodium falciparum to drugs that bind DNA or inhibit its synthesis","volume":"79","author":"Lee","year":"1993","journal-title":"J. Parasitol."},{"issue":"12","key":"10.1016\/j.ijpddr.2025.100606_bib54","first-page":"1983","article-title":"UpSet: visualization of intersecting sets IEEE transactions on visualization and computer graphics","volume":"20","author":"Lex","year":"2014","journal-title":"InfoVis"},{"issue":"5","key":"10.1016\/j.ijpddr.2025.100606_bib55","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0097775","article-title":"A Meta analysis on risks of adverse pregnancy outcomes in Toxoplasma gondii infection","volume":"9","author":"Li","year":"2014","journal-title":"PLoS One"},{"issue":"11","key":"10.1016\/j.ijpddr.2025.100606_bib56","doi-asserted-by":"crossref","first-page":"2147","DOI":"10.1021\/jm00394a037","article-title":"Antimalarial activity of new water-soluble dihydroartemisinin derivatives","volume":"30","author":"Lin","year":"1987","journal-title":"J. Med. Chem."},{"issue":"8","key":"10.1016\/j.ijpddr.2025.100606_bib57","doi-asserted-by":"crossref","first-page":"1498","DOI":"10.1128\/AAC.34.8.1498","article-title":"In vitro cultivation of Cryptosporidium parvum and screening for anticryptosporidial drugs","volume":"34","author":"McDonald","year":"1990","journal-title":"Antimicrob. Agents Chemother."},{"issue":"11","key":"10.1016\/j.ijpddr.2025.100606_bib58","doi-asserted-by":"crossref","first-page":"1748","DOI":"10.2460\/ajvr.1978.39.11.1748","article-title":"Monensin for the prevention of coccidiosis in calves","volume":"39","author":"McDougald","year":"1978","journal-title":"Am. J. Vet. Res."},{"issue":"1","key":"10.1016\/j.ijpddr.2025.100606_bib59","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0166-6851(00)00184-5","article-title":"Characterization of cytochrome b from Toxoplasma gondii and Qo domain mutations as a mechanism of atovaquone-resistance","volume":"108","author":"McFadden","year":"2000","journal-title":"Mol. Biochem. Parasitol."},{"issue":"2","key":"10.1016\/j.ijpddr.2025.100606_bib60","first-page":"291","article-title":"Recommended management of Toxoplasma gondii infection in pregnant women and their children","volume":"69","author":"Milewska-Bobula","year":"2015","journal-title":"Prz. Epidemiol."},{"issue":"4","key":"10.1016\/j.ijpddr.2025.100606_bib61","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1016\/j.exppara.2006.10.004","article-title":"Roxithromycin potentiates the effects of chloroquine and mefloquine on multidrug-resistant Plasmodium falciparum in vitro","volume":"115","author":"Min","year":"2007","journal-title":"Exp. Parasitol."},{"issue":"3","key":"10.1016\/j.ijpddr.2025.100606_bib62","doi-asserted-by":"crossref","first-page":"188","DOI":"10.7164\/antibiotics.57.188","article-title":"Pladienolides, new substances from culture of Streptomyces platensis Mer-11107. III. In vitro and in vivo antitumor activities","volume":"57","author":"Mizui","year":"2004","journal-title":"J. Antibiot."},{"issue":"35","key":"10.1016\/j.ijpddr.2025.100606_bib63","doi-asserted-by":"crossref","first-page":"6707","DOI":"10.1016\/j.tet.2011.04.051","article-title":"Isolation and characterization of actinoramides A-C, highly modified peptides from a marine streptomyces sp","volume":"67","author":"Nam","year":"2011","journal-title":"Tetrahedron"},{"issue":"3","key":"10.1016\/j.ijpddr.2025.100606_bib64","doi-asserted-by":"crossref","first-page":"770","DOI":"10.1021\/acs.jnatprod.9b01285","article-title":"Natural products as sources of new drugs over the nearly four decades from 01\/1981 to 09\/2019","volume":"83","author":"Newman","year":"2020","journal-title":"J. Nat. Prod."},{"key":"10.1016\/j.ijpddr.2025.100606_bib65","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1007\/PL00008580","article-title":"Improved methods for examination of Toxoplasma gondii cytoskeleton at ultrastructural level","volume":"87","author":"Oliveira-Lima","year":"2001","journal-title":"Parasitol. Res."},{"issue":"5","key":"10.1016\/j.ijpddr.2025.100606_bib66","first-page":"1650","article-title":"Cytochalasin releases mRNA from the cytoskeletal framework and inhibits protein synthesis","volume":"6","author":"Ornelles","year":"1986","journal-title":"Mol. Cell Biol."},{"issue":"10","key":"10.1016\/j.ijpddr.2025.100606_bib67","doi-asserted-by":"crossref","DOI":"10.1128\/AAC.00267-21","article-title":"Inhibitory compounds targeting Plasmodium falciparum gyrase B","volume":"65","author":"Pakosz","year":"2021","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.ijpddr.2025.100606_bib68","doi-asserted-by":"crossref","first-page":"1385","DOI":"10.1016\/j.ijpara.2009.04.003","article-title":"Toxoplasmosis snapshots: global status of Toxoplasma gondii seroprevalence and implications for pregnancy and congenital toxoplasmosis","volume":"39","author":"Pappas","year":"2009","journal-title":"Int. J. Parasitol."},{"issue":"6","key":"10.1016\/j.ijpddr.2025.100606_bib69","doi-asserted-by":"crossref","first-page":"2248","DOI":"10.1128\/AAC.01462-08","article-title":"Atorvastatin is a promising partner for antimalarial drugs in treatment of Plasmodium falciparum malaria","volume":"53","author":"Parquet","year":"2009","journal-title":"Antimicrob. Agents Chemother."},{"issue":"139","key":"10.1016\/j.ijpddr.2025.100606_bib70","article-title":"Atorvastatin as a potential anti-malarial drug: in vitro synergy in combinational therapy with quinine against Plasmodium falciparum","volume":"9","author":"Parquet","year":"2010","journal-title":"Malar. J."},{"issue":"1","key":"10.1016\/j.ijpddr.2025.100606_bib71","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0145812","article-title":"Discovery of new compounds active against Plasmodium falciparum by high throughput screening of microbial natural products","volume":"11","author":"P\u00e9rez-Moreno","year":"2016","journal-title":"PLoS One"},{"issue":"5","key":"10.1016\/j.ijpddr.2025.100606_bib72","doi-asserted-by":"crossref","first-page":"1091","DOI":"10.1046\/j.1365-2958.2001.02595.x","article-title":"The pleuromutilin drugs tiamulin and valnemulin bind to the RNA at the peptidyl transferase centre on the ribosome","volume":"41","author":"Poulsen","year":"2001","journal-title":"Mol. Microbiol."},{"issue":"6","key":"10.1016\/j.ijpddr.2025.100606_bib73","doi-asserted-by":"crossref","first-page":"1746","DOI":"10.1128\/AAC.45.6.1746-1750.2001","article-title":"In vitro activities of antibiotics against Plasmodium falciparum are inhibited by iron","volume":"45","author":"Pradines","year":"2001","journal-title":"Antimicrob. Agents Chemother."},{"issue":"1","key":"10.1016\/j.ijpddr.2025.100606_bib74","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1186\/s12936-017-1937-2","article-title":"Exploring anti-malarial potential of FDA approved drugs: an in silico approach","volume":"16","author":"Ramakrishnan","year":"2017","journal-title":"Malar. J."},{"issue":"5","key":"10.1016\/j.ijpddr.2025.100606_bib75","doi-asserted-by":"crossref","first-page":"1610","DOI":"10.1002\/chem.200601236","article-title":"Kibdelones: novel anticancer polyketides from a rare Australian actinomycete","volume":"13","author":"Ratnayake","year":"2007","journal-title":"Chemistry"},{"issue":"3","key":"10.1016\/j.ijpddr.2025.100606_bib76","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1128\/AAC.42.3.715","article-title":"The antibiotic Micrococcin is a potent inhibitor of growth and protein synthesis in the malaria parasite","volume":"42","author":"Rogers","year":"1998","journal-title":"Antimicrob. Agents Chemother."},{"issue":"4","key":"10.1016\/j.ijpddr.2025.100606_bib77","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/S1473-3099(18)30066-5","article-title":"Burden, pathology, and costs of malaria in pregnancy: new developments for an old problem","volume":"18","author":"Rogerson","year":"2018","journal-title":"Lancet Infect. Dis."},{"issue":"6","key":"10.1016\/j.ijpddr.2025.100606_bib78","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1016\/0165-6147(89)90263-0","article-title":"Staurosporine, K-252 and UCN-01: potent but nonspecific inhibitors of protein kinases","volume":"10","author":"R\u00fcegg","year":"1989","journal-title":"Trends Pharmacol. Sci."},{"issue":"33","key":"10.1016\/j.ijpddr.2025.100606_bib79","doi-asserted-by":"crossref","first-page":"10561","DOI":"10.1021\/jacs.6b05484","article-title":"Synthesis and biological evaluation of Kibdelone C and its simplified derivatives","volume":"138","author":"Rujirawanich","year":"2016","journal-title":"J. Am. Chem. Soc."},{"key":"10.1016\/j.ijpddr.2025.100606_bib80","doi-asserted-by":"crossref","first-page":"3317","DOI":"10.1002\/anie.200906988","article-title":"Antiplasmodial Thiostrepton derivatives: proteasome inhibitors with a dual mode of action","volume":"49","author":"Schoof","year":"2010","journal-title":"Angew. Chem. Int. Ed."},{"issue":"6","key":"10.1016\/j.ijpddr.2025.100606_bib81","doi-asserted-by":"crossref","first-page":"3174","DOI":"10.1128\/AAC.04294-14","article-title":"In vitro antimalarial activity of novel semisynthetic nocathiacin I antibiotics","volume":"59","author":"Sharma","year":"2015","journal-title":"Antimicrob. Agents Chemother."},{"issue":"4","key":"10.1016\/j.ijpddr.2025.100606_bib82","doi-asserted-by":"crossref","first-page":"366","DOI":"10.7164\/antibiotics.29.366","article-title":"Isolation of three new antibiotics, thiocillins I, II and III, related to micrococcin P. Studies on antibiotics from the genus Bacillus. VIII","volume":"29","author":"Shoji","year":"1976","journal-title":"J. Antibiot. (Tokyo)"},{"issue":"10","key":"10.1016\/j.ijpddr.2025.100606_bib83","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1038\/s41573-023-00772-9","article-title":"Antimalarial drug discovery: progress and approaches","volume":"22","author":"Siqueira-Neto","year":"2023","journal-title":"Nat. Rev. Drug Discov."},{"issue":"13","key":"10.1016\/j.ijpddr.2025.100606_bib84","article-title":"Atorvastatin treatment is effective when used in combination with mefloquine in an experimental cerebral malaria murine model","volume":"11","author":"Souraud","year":"2012","journal-title":"Malar. J."},{"issue":"4","key":"10.1016\/j.ijpddr.2025.100606_bib85","doi-asserted-by":"crossref","first-page":"704","DOI":"10.1046\/j.1365-2958.1999.01515.x","article-title":"Resistance mutations reveal the atovaquone\u2010binding domain of cytochrome b in malaria parasites","volume":"33","author":"Srivastava","year":"1999","journal-title":"Mol. Microbiol."},{"issue":"12","key":"10.1016\/j.ijpddr.2025.100606_bib86","doi-asserted-by":"crossref","first-page":"3542","DOI":"10.1038\/s41375-021-01328-9","article-title":"Phase I first-in-human Dose Escalation study of the oral SF3B1 modulator H3B-8800 in myeloid neoplasms","volume":"35","author":"Steensma","year":"2021","journal-title":"Leukemia"},{"issue":"7","key":"10.1016\/j.ijpddr.2025.100606_bib87","doi-asserted-by":"crossref","first-page":"893","DOI":"10.3390\/antibiotics11070893","article-title":"Chemotherapeutic strategies with valnemulin, tilmicosin, and tulathromycin to control Mycoplasma hyopneumoniae infection in pigs","volume":"11","author":"Stingelin","year":"2022","journal-title":"Antibiotics (Basel)"},{"issue":"2849","key":"10.1016\/j.ijpddr.2025.100606_bib88","article-title":"Inhibitors of the Plasmodium falciparum Hsp90 towards selective antimalarial drug design: the past, present and future","volume":"10","author":"Stofberg","year":"2021","journal-title":"Cells"},{"issue":"4","key":"10.1016\/j.ijpddr.2025.100606_bib89","doi-asserted-by":"crossref","DOI":"10.1128\/AAC.02388-17","article-title":"Unraveling the metabolic routes of retapamulin: insights into drug development of pleuromutilins","volume":"62","author":"Sun","year":"2018","journal-title":"Antimicrob. Agents Chemother."},{"issue":"656","key":"10.1016\/j.ijpddr.2025.100606_bib90","article-title":"Altiratinib blocks Toxoplasma gondii and Plasmodium falciparum development by selectively targeting a spliceosome kinase","volume":"14","author":"Swale","year":"2022","journal-title":"Infectious Diseases"},{"issue":"3","key":"10.1016\/j.ijpddr.2025.100606_bib91","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1006\/expr.1998.4254","article-title":"Plasmodium falciparum: characterization of organelle migration during merozoite morphogenesis in asexual malaria infections","volume":"88","author":"Taraschi","year":"1998","journal-title":"Exp. Parasitol."},{"issue":"1","key":"10.1016\/j.ijpddr.2025.100606_bib92","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/j.molbiopara.2011.05.004","article-title":"Transcript-level responses of Plasmodium falciparum to thiostrepton","volume":"179","author":"Tarr","year":"2011","journal-title":"Mol. Biochem. Parasitol."},{"issue":"7","key":"10.1016\/j.ijpddr.2025.100606_bib93","doi-asserted-by":"crossref","first-page":"501","DOI":"10.2471\/BLT.12.111732","article-title":"The global burden of congenital toxoplasmosis: a systematic review","volume":"91","author":"Torgerson","year":"2013","journal-title":"Bull. World Health Organ."},{"issue":"4254","key":"10.1016\/j.ijpddr.2025.100606_bib94","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1126\/science.781840","article-title":"Human malaria parasites in continuous culture","volume":"193","author":"Trager","year":"1976","journal-title":"Science"},{"key":"10.1016\/j.ijpddr.2025.100606_bib95","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1038\/ja.2012.113","article-title":"Antimalarial C-9 oxime derivatives from desmycosin, produced by click chemistry","volume":"66","author":"Tsutsui","year":"2013","journal-title":"J. Antibiot."},{"issue":"35","key":"10.1016\/j.ijpddr.2025.100606_bib96","doi-asserted-by":"crossref","first-page":"10210","DOI":"10.1002\/anie.201601967","article-title":"Artemisinin-A gift from traditional Chinese medicine to the world (nobel lecture)","volume":"55","author":"Tu","year":"2016","journal-title":"Angew. Chem. Int. Ed."},{"issue":"1","key":"10.1016\/j.ijpddr.2025.100606_bib97","doi-asserted-by":"crossref","DOI":"10.1128\/AAC.01161-17","article-title":"Validation of putative apicoplast-targeting drugs using a chemical supplementation assay in cultured human malaria parasites","volume":"62","author":"Uddin","year":"2018","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.ijpddr.2025.100606_bib98","first-page":"885","article-title":"Mode of action of trichothecenes","volume":"31","author":"Ueno","year":"1977","journal-title":"Annales de la nutrition et de l'alimentation"},{"issue":"1","key":"10.1016\/j.ijpddr.2025.100606_bib99","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1093\/jac\/38.1.75","article-title":"Anti-toxoplasma effect of pyrimethamine, trimethoprim and sulphonamides alone and in combination: implications for therapy","volume":"38","author":"van der Ven","year":"1996","journal-title":"J. Antimicrob. Chemother."},{"issue":"3","key":"10.1016\/j.ijpddr.2025.100606_bib100","doi-asserted-by":"crossref","first-page":"630","DOI":"10.1016\/j.bmc.2017.12.027","article-title":"Structure-activity relationships of cryptopleurine analogs with E-ring modifications as anti-hepatitis C virus agents","volume":"26","author":"Wang","year":"2018","journal-title":"Bioorg. Med. Chem."},{"issue":"6","key":"10.1016\/j.ijpddr.2025.100606_bib101","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1177\/0091270008318006","article-title":"Dose- and time-dependent pharmacokinetics of midostaurin in patients with diabetes mellitus","volume":"48","author":"Wang","year":"2008","journal-title":"J. Clin. Pharmacol."},{"key":"10.1016\/j.ijpddr.2025.100606_bib102","series-title":"The Selection and Use of Essential Medicines 2023: Executive Summary of the Report of the 24th WHO Expert Committee on the Selection and Use of Essential Medicines, 24 \u2013 28 April 2023","article-title":"World health organization model list of essential medicines \u2013 23rd list, 2023","author":"Web Annex","year":"2023"},{"issue":"9","key":"10.1016\/j.ijpddr.2025.100606_bib103","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0138204","article-title":"A systematic review and meta-analysis of the efficacy of anti-toxoplasma gondii medicines in humans","volume":"10","author":"Wei","year":"2015","journal-title":"PLoS One"},{"key":"10.1016\/j.ijpddr.2025.100606_bib104","series-title":"ggplot2: Elegant Graphics for Data Analysis","author":"Wickham","year":"2016"},{"issue":"15","key":"10.1016\/j.ijpddr.2025.100606_bib105","doi-asserted-by":"crossref","first-page":"3936","DOI":"10.1021\/ol2014494","article-title":"Padanamides A and B, highly modified linear tetrapeptides produced in culture by a Streptomyces sp. isolated from a marine sediment","volume":"13","author":"Williams","year":"2011","journal-title":"Org. Lett."},{"issue":"52","key":"10.1016\/j.ijpddr.2025.100606_bib106","article-title":"Macrolides rapidly inhibit red blood cell invasion by the human malaria parasite, Plasmodium falciparum","volume":"13","author":"Wilson","year":"2015","journal-title":"BMC Biol."},{"issue":"3","key":"10.1016\/j.ijpddr.2025.100606_bib107","doi-asserted-by":"crossref","first-page":"1455","DOI":"10.1128\/AAC.01881-12","article-title":"Defining the timing of action of antimalarial drugs against Plasmodium falciparum","volume":"57","author":"Wilson","year":"2013","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.ijpddr.2025.100606_bib108","series-title":"World Health Organization","year":"2023"},{"issue":"11","key":"10.1016\/j.ijpddr.2025.100606_bib109","doi-asserted-by":"crossref","first-page":"4683","DOI":"10.1016\/j.apsb.2024.08.027","article-title":"Solubilization techniques used for poorly water-soluble drugs","volume":"14","author":"Xie","year":"2024","journal-title":"Acta Pharm. Sin. B"},{"issue":"11","key":"10.1016\/j.ijpddr.2025.100606_bib110","doi-asserted-by":"crossref","first-page":"3875","DOI":"10.1128\/AAC.00184-06","article-title":"Biochemical characterization of the interactions of the novel pleuromutilin derivative retapamulin with bacterial ribosomes","volume":"50","author":"Yan","year":"2006","journal-title":"Antimicrob. Agents Chemother."},{"issue":"1","key":"10.1016\/j.ijpddr.2025.100606_bib111","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/0001-706X(94)90039-6","article-title":"The in vitro antimalarial activity of chloramphenicol against Plasmodium falciparum","volume":"56","author":"Yeo","year":"1994","journal-title":"Acta Trop."},{"issue":"84","key":"10.1016\/j.ijpddr.2025.100606_bib112","first-page":"1","article-title":"Transcriptional changes in Toxoplasma gondii in response to treatment with monensin","volume":"13","author":"Zhai","year":"2020","journal-title":"Parasite Vectors"}],"container-title":["International Journal for Parasitology: Drugs and Drug Resistance"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2211320725000296?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2211320725000296?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,3,7]],"date-time":"2026-03-07T15:26:32Z","timestamp":1772897192000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2211320725000296"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12]]},"references-count":112,"alternative-id":["S2211320725000296"],"URL":"https:\/\/doi.org\/10.1016\/j.ijpddr.2025.100606","relation":{},"ISSN":["2211-3207"],"issn-type":[{"value":"2211-3207","type":"print"}],"subject":[],"published":{"date-parts":[[2025,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Screening and hit evaluation of a microbial metabolite library against the pathogenic Plasmodium falciparum and Toxoplasma gondii parasites","name":"articletitle","label":"Article Title"},{"value":"International Journal for Parasitology: Drugs and Drug Resistance","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ijpddr.2025.100606","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Published by Elsevier Ltd on behalf of Australian Society for Parasitology.","name":"copyright","label":"Copyright"}],"article-number":"100606"}}